Influence of chronic dosing on theophylline clearance. 1984

H Efthimiou, and D J Morgan, and L Ioannides-Demos, and K Raymond, and A J McLean

Theophylline clearance was studied in normal healthy volunteers before and after chronic oral dosing. Oral theophylline clearance showed a significant decrease (P less than 0.001) from 59.3 +/- 6.48 ml/min (mean +/- s.e. mean, n = 10) to 48.0 +/- 6.4 ml/min. Steady-state intravenous clearance decreased by 26 +/- 2% from 55.1 +/- 7.7 ml/min to 41.0 +/- 5.96 ml/min (mean +/- s.e. mean, n = 6; P less than 0.001) at constant steady-state intravenous test concentrations (mean 15.0 +/- 1.6 micrograms/ml after chronic oral dosing), excluding significant concentration dependence. Extrapolation of acute clearance findings to maintenance requirement may not be valid even in the same individual, with theophylline therapy requiring on-going review beyond acute stabilisation.

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D005260 Female Females
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013806 Theophylline A methyl xanthine derivative from tea with diuretic, smooth muscle relaxant, bronchial dilation, cardiac and central nervous system stimulant activities. Theophylline inhibits the 3',5'-CYCLIC NUCLEOTIDE PHOSPHODIESTERASE that degrades CYCLIC AMP thus potentiates the actions of agents that act through ADENYLYL CYCLASES and cyclic AMP. 1,3-Dimethylxanthine,3,7-Dihydro-1,3-dimethyl-1H-purine-2,6-dione,Accurbron,Aerobin,Aerolate,Afonilum Retard,Aquaphyllin,Armophylline,Bronchoparat,Bronkodyl,Constant-T,Elixophyllin,Euphylong,Glycine Theophyllinate,Lodrane,Monospan,Nuelin,Nuelin S.A.,Quibron T-SR,Slo-Phyllin,Somophyllin-T,Sustaire,Synophylate,Theo Von Ct,Theo-24,Theo-Dur,Theobid,Theocin,Theoconfin Continuous,Theodur,Theolair,Theolix,Theon,Theonite,Theopek,Theophylline Anhydrous,Theophylline Sodium Glycinate,Theospan,Theostat,Theovent,Uniphyl,Uniphyllin,Uniphylline,1,3 Dimethylxanthine,Anhydrous, Theophylline,Constant T,ConstantT,Ct, Theo Von,Glycinate, Theophylline Sodium,Quibron T SR,Quibron TSR,Slo Phyllin,SloPhyllin,Sodium Glycinate, Theophylline,Somophyllin T,SomophyllinT,Theo 24,Theo Dur,Theo24,Theophyllinate, Glycine,Von Ct, Theo
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

H Efthimiou, and D J Morgan, and L Ioannides-Demos, and K Raymond, and A J McLean
May 1985, British journal of clinical pharmacology,
H Efthimiou, and D J Morgan, and L Ioannides-Demos, and K Raymond, and A J McLean
May 1985, British journal of clinical pharmacology,
H Efthimiou, and D J Morgan, and L Ioannides-Demos, and K Raymond, and A J McLean
May 1984, Clinical pharmacology and therapeutics,
H Efthimiou, and D J Morgan, and L Ioannides-Demos, and K Raymond, and A J McLean
December 1986, British journal of clinical pharmacology,
H Efthimiou, and D J Morgan, and L Ioannides-Demos, and K Raymond, and A J McLean
January 1991, International journal of clinical pharmacology research,
H Efthimiou, and D J Morgan, and L Ioannides-Demos, and K Raymond, and A J McLean
January 1981, Clinical pharmacokinetics,
H Efthimiou, and D J Morgan, and L Ioannides-Demos, and K Raymond, and A J McLean
November 1987, International journal of clinical pharmacology, therapy, and toxicology,
H Efthimiou, and D J Morgan, and L Ioannides-Demos, and K Raymond, and A J McLean
January 1985, Developmental pharmacology and therapeutics,
H Efthimiou, and D J Morgan, and L Ioannides-Demos, and K Raymond, and A J McLean
November 1988, Annals of allergy,
H Efthimiou, and D J Morgan, and L Ioannides-Demos, and K Raymond, and A J McLean
January 1982, Journal of clinical pharmacology,
Copied contents to your clipboard!